OR WAIT 15 SECS
Novella Clinical and the Cardiovascular Research Foundation announced a preferred provider collaboration.
Novella Clinical, a Quintiles company, and the Cardiovascular Research Foundation announced a preferred provider collaboration that will offer a set of clinical trial services to developers of cardiovascular drugs and devices. Novella, is a full-service clinical research organization with specialization in cardiovascular medical device research, and the Cardiovascular Research Foundation Clinical Trials Center, the academic research organization of the Foundation, with its extensive group of cardiovascular physicians and core labs, will work together to provide sponsors comprehensive clinical research services-from preclinical to post-market studies.
Read the full release here.